← Eichor
Study identifier: NCT06888024 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Pelvic Vein Quantitative Flow Characterization Using 2D and 4D Flow MRI

Condition: May-Thurner Syndrome · Iliac Venous Compression  ·  Sponsor: Ningcheng Peter Li

PhaseNA
Planned participants15
Who can joinAll sexes, 18 Years to 89 Years
Healthy volunteersYes

About this study

The purpose of the study is to quantitatively characterize the flow in the pelvic venous structures using 2D and 4D flow MRI with the objective of establishing physiologic and pathologic parameters for downstream computational fluid dynamics analysis. Arm 1: To establish the baseline flow characteristics of the iliac veins in patients with no imaging evidence of iliac venous disease. Arm 2: To assess the flow characteristics of the iliac veins in patients with left iliac vein compression syndrome (a.k.a. May-Thurner syndrome). Arm 3: To assess the flow characteristics of the iliac veins in patients status post iliac stent placement.

This description comes directly from the study's public registry record.

Talk to the study team

Noelle Bodkin  ·  774-441-8442.  ·  noelle.bodkin@umassmed.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of MassachusettsWorcester, Massachusetts, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06888024